Key result
Combining antidepressants and certain opioids triggers life-threatening serotonin syndrome.
Why the study?
Serotonin syndrome is a potentially life-threatening toxidrome, prompting this review of its pathophysiology, clinical manifestations, and high-risk medications with a focus on chronic pain therapy.
Physicians managing chronic pain must be vigilant about the risk of serotonin syndrome when co-prescribing serotonergic antidepressants and certain opioids like tramadol.
Answers are grounded in this paper and cite their sources.
May warrant caution with serotonergic combinations in pain management; leaves open prospective quantification of incidence and prevention.
SerotoninovĂ˝ syndrom je potenciĂĄlnÄ Ĺživot ohroĹžujĂcĂ toxidrom spojenĂ˝ se zvýťenou serotoninergnĂ aktivitou v perifernĂm i v centrĂĄlnĂm nervovĂŠm systĂŠmu. Je charakterizovĂĄn celĂ˝m spektrem klinickĂ˝ch projevĹŻ zahrnujĂcĂm zmÄny mentĂĄlnĂho stavu, vegetativnĂ nestability a znĂĄmky hyperexcitability CNS se svalovĂ˝mi projevy. MĹŻĹže vzniknout obvykle pĹi souÄasnĂŠm podĂĄvĂĄnĂ 2 nebo vĂce serotoninergnĂch lĂĄtek, pĹiÄemĹž zvlĂĄĹĄĹĽ nebezpeÄnĂŠ jsou kombinace zahrnujĂcĂ inhibitory monoaminooxidĂĄzy (IMAO), ale vznik pĹi monoterapii je tĂŠĹž moĹžnĂ˝. Tento pĹehled popisuje patofyziologii vzniku a klinickĂŠ projevy tohoto syndromu a rizikovĂŠ skupiny lĂŠkĹŻ se zvlĂĄĹĄtnĂm zamÄĹenĂm na lĂŠky pouĹžĂvanĂŠ pĹi lĂŠÄbÄ chronickĂŠ bolesti.
No takes yet. Share an insight, caveat, or question.
Jan Procházka (2024) conducted a review in Serotonin syndrome. Serotonergic drugs (analgesics, antidepressants) was evaluated. Serotonin syndrome is a potentially life-threatening toxidrome caused by increased serotonergic activity, often triggered by combinations of serotonergic drugs such as antidepressants and certain opioids used in pain management.
Synapse has enriched 10 related papers. Consider them for comparative context: